Current Ratio of TScan Therapeutics, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
TScan Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • TScan Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 753%, a 1.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

TScan Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q4 2025 753% -12% -1.6% 31 Dec 2025
Q3 2025 758% +32% +4.4% 30 Sep 2025
Q2 2025 829% +171% +26% 30 Jun 2025
Q1 2025 843% +211% +33% 31 Mar 2025
Q4 2024 766% +92% +14% 31 Dec 2024
Q3 2024 726% +38% +5.5% 30 Sep 2024
Q2 2024 659% -74% -10% 30 Jun 2024
Q1 2024 632% -129% -17% 31 Mar 2024
Q4 2023 673% -104% -13% 31 Dec 2023
Q3 2023 687% -104% -13% 30 Sep 2023
Q2 2023 732% -53% -6.7% 30 Jun 2023
Q1 2023 761% +31% +4.3% 31 Mar 2023
Q4 2022 777% 31 Dec 2022
Q3 2022 791% 30 Sep 2022
Q2 2022 785% 30 Jun 2022
Q1 2022 730% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.